Alembic Pharmaceuticals (APLLTD) Share Price Hits Fresh 52-Week High of Rs 1,072.50, Trades at Rs 1,070.90
- November 16, 2026
- Posted by: Kunal Singla
- Category: News
Alembic Pharmaceuticals share price is Rs 1,070.90 as of 16 November 2026 at 11:22 AM IST, up Rs 41.20 or 4.00% from the previous close of Rs 1,029.70, after the stock touched a fresh 52-week high of Rs 1,072.50. Alembic Pharmaceuticals Ltd. (APLLTD) has a market capitalisation of Rs 20,240.10 crore, and the Alembic Pharmaceuticals 52 week high is among today’s stock updates from the Indian stock market.
The stock opened at Rs 1,038.10 and has moved between Rs 1,035.00 and Rs 1,072.50 so far today. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. This Alembic Pharmaceuticals stock news update therefore rests on verified price levels and the company’s reported fundamentals, which Univest explains in the sections below.
Alembic Pharmaceuticals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,070.9 |
| Previous Close | Rs 1,029.7 |
| Today's Move | +Rs 41.2 (+4%) |
| Open | Rs 1,038.1 |
| High | Rs 1,072.5 |
| Low | Rs 1,035 |
| Market Capitalisation | Rs 20,240.1 crore |
Alembic Pharmaceuticals operates in the Pharmaceuticals & Drugs industry. Its latest quarterly revenue for Sep 2026 is Rs 2,603.48 crore, its P/E ratio is 23.98 and its ROE is 12.35%. Readers tracking the Alembic Pharmaceuticals share price today can monitor three things next: whether the stock stays near its one-year high, how its P/E ratio compares with peers, and the next financial results update from the company.
Alembic Pharmaceuticals Ltd. (APLLTD) traded at Rs 1,070.9 versus the previous close of Rs 1,029.7, a rise of 4%. The stock opened at Rs 1,038.1, reached a high of Rs 1,072.5 and touched a low of Rs 1,035.
Alembic Pharmaceuticals share price today is Rs 1,070.90, a gain of 4.00% over the previous close of Rs 1,029.70. The stock touched a fresh 52-week high of Rs 1,072.50 during the session, which places it among the 52 week high stocks on the Indian stock market today.
The day began with an open of Rs 1,038.10, which is above the previous close of Rs 1,029.70. The intraday low was Rs 1,035.00, and the day high of Rs 1,072.50 is the same level as the new Alembic Pharmaceuticals 52 week high. The latest price of Rs 1,070.90 sits Rs 1.60 below that high and Rs 35.90 above the day low.
In rupee terms, the stock has added Rs 41.20 per share since the previous close. This Alembic Pharmaceuticals share price update reflects intraday levels as of 16 November 2026 at 11:22 AM IST, and the figures can change while the market remains open. The Alembic Pharmaceuticals one year high and the Alembic Pharmaceuticals share price live quote will move with the session.
With Alembic Pharmaceuticals stock performance at a one-year peak, the valuation and return ratios of the company add the next layer of context for readers following the Alembic Pharmaceuticals share price.
Alembic Pharmaceuticals Ltd. (APLLTD) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 20,240.1 crore |
| P/E Ratio | 23.98x |
| P/B Ratio | 3.4x |
| ROE | 12.35% |
| ROCE | 11.74% |
| EPS | Rs 42.93 |
| Book Value Per Share | Rs 302.42 |
| Dividend Yield | 1.17% |
Alembic Pharmaceuticals Ltd. (APLLTD) fundamental metrics show P/E 23.98x, P/B 3.4x, ROE 12.35%, ROCE 11.74%. These figures provide context only and are not a buy or sell signal.
Alembic Pharmaceuticals Ltd. has a market capitalisation of Rs 20,240.1 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 23.98x, P/B at 3.4x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.35% and ROCE of 11.74%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 42.93, book value per share of Rs 302.42, dividend yield of 1.17%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.02x, median ROE of 10.97%, median ROCE of 12.7%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 23.98x |
| Benchmark Median P/E | 31.02x |
| Benchmark Average P/E | 52.38x |
| Benchmark P/E Range | 2.6x to 1,177x |
| Company P/B Ratio | 3.4x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 12.35% |
| Benchmark Median ROE | 10.97% |
| Company ROCE | 11.74% |
| Benchmark Median ROCE | 12.7% |
| Company Market Capitalisation | Rs 20,240.1 crore |
| Benchmark Median Market Cap | Rs 677.13 crore |
Alembic Pharmaceuticals Ltd. (APLLTD) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Alembic Pharmaceuticals Ltd. (APLLTD) has a P/E ratio of 23.98x, which is below the benchmark median of 31.02x, a difference of -22.7%. On its own, the P/E gap is a valuation reference point, not a trading call.
Alembic Pharmaceuticals Ltd. (APLLTD) has a ROE of 12.35%, which is above the benchmark median of 10.97%, a difference of +12.58%. Alembic Pharmaceuticals Ltd. (APLLTD) has a ROCE of 11.74%, which is below the benchmark median of 12.7%, a difference of -7.56%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Shilpa Medicare Ltd. | SHILPAMED | 19,423.23 | 58.43 | 7.04 | 9.82 | 11.43 |
| Granules India Ltd. | GRANULES | 22,205.64 | 31.12 | 3.38 | 14.13 | 15.74 |
| Eris Lifesciences Ltd. | ERIS | 18,167.12 | 25.68 | 4.38 | 19.23 | 14.47 |
| Caplin Point Laboratories Ltd. | CAPLIPOINT | 18,140.19 | 26.33 | 4.65 | 20.79 | 24.97 |
| Glenmark Life Sciences Ltd. | ALIVUS | 17,945.84 | 26.8 | 4.94 | 18.41 | 24.61 |
Alembic Pharmaceuticals Ltd. (APLLTD) has a P/E ratio of 23.98x compared with the displayed peer median of 26.8x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 12.35% compares with a peer median of 18.41% across the companies shown in the table. ROCE stood at 11.74% versus the displayed peer median of 15.74%, providing a capital-efficiency comparison. Alembic Pharmaceuticals Ltd. (APLLTD) has a market capitalisation of Rs 20,240.1 crore. Among the 5 peers shown, 1 has a larger market capitalisation.
Why Investors Are Watching Alembic Pharmaceuticals
- Alembic Pharmaceuticals share price is Rs 1,070.90, up 4.00% from the previous close of Rs 1,029.70.
- The stock touched a fresh 52-week high of Rs 1,072.50 today.
- The P/E ratio of 23.98 compares with an industry median of 31.02 across 170 companies.
- ROE of 12.35% is above the industry median of 10.97%, while ROCE of 11.74% is below the median of 12.70%.
- Latest quarterly revenue for Sep 2026 is Rs 2,603.48 crore against a market cap of Rs 20,240.10 crore.
About Alembic Pharmaceuticals
Alembic Pharmaceuticals Ltd. (APLLTD) is classified under the Healthcare sector and the Pharmaceuticals & Drugs industry on Univest. The company has a market capitalisation of Rs 20,240.10 crore and a latest quarterly revenue of Rs 2,603.48 crore for Sep 2026.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
What is the Alembic Pharmaceuticals share price today?
Ans. Alembic Pharmaceuticals share price is Rs 1,070.90 as of 16 November 2026 at 11:22 AM IST, up Rs 41.20 or 4.00% from the previous close of Rs 1,029.70. The stock opened at Rs 1,038.10 and the day low is Rs 1,035.00.
Has Alembic Pharmaceuticals hit a 52-week high today?
Ans. Yes. Alembic Pharmaceuticals touched a fresh 52-week high of Rs 1,072.50 today, which is also the day high. The stock now trades at Rs 1,070.90, which is Rs 1.60 below that level, after opening at Rs 1,038.10 this morning.
Why is the Alembic Pharmaceuticals share price rising today?
Ans. Alembic Pharmaceuticals share price is up 4.00% today, from Rs 1,029.70 to Rs 1,070.90. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The move is described only through verified price levels and fundamentals.
What is the Alembic Pharmaceuticals market cap?
Ans. Alembic Pharmaceuticals market cap is Rs 20,240.10 crore at the current price. This is above the Pharmaceuticals & Drugs industry median market capitalisation of Rs 677.13 crore and the average of Rs 14,512.53 crore across the 203 companies in the benchmark.
What is the Alembic Pharmaceuticals P/E ratio?
Ans. Alembic Pharmaceuticals has a P/E ratio of 23.98 and a P/B ratio of 3.40. The Pharmaceuticals & Drugs industry median P/E is 31.02 and the median P/B is 2.88, so the P/E sits below the benchmark median and the P/B sits above it.
What are the Alembic Pharmaceuticals ROE and ROCE?
Ans. Alembic Pharmaceuticals reports ROE of 12.35% and ROCE of 11.74%. The ROE is above the industry median of 10.97%, while the ROCE is below the industry median of 12.70% on the latest Univest figures.
What are the Alembic Pharmaceuticals EPS and book value?
Ans. Alembic Pharmaceuticals has an EPS of Rs 42.93 and a book value of Rs 302.42 per share. Dividend yield is 1.17%, which reflects the historical payout relative to its current share price of Rs 1,070.90 today.
What is the latest quarterly revenue of Alembic Pharmaceuticals?
Ans. Alembic Pharmaceuticals reported revenue of Rs 2,603.48 crore for Sep 2026, according to latest Univest data. This sits alongside a market capitalisation of Rs 20,240.10 crore and a P/E ratio of 23.98 for the company.
Track Alembic Pharmaceuticals Share Price on Univest
Use Alembic Pharmaceuticals Ltd. (APLLTD) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Users can track the live Alembic Pharmaceuticals share price, key fundamental ratios, 52-week levels and market insights on Univest. Univest also lists other stocks in news, market movers and 52 week high stocks, along with NSE news, BSE news and stock updates for the Indian stock market.